Looking for more reliable biomarkers in breast cancer: Comparison between routine methods and RT-qPCR.
Emanuele CaselliCristina PellicciaValeria TetiGuido BellezzaMartina MandaranoIvana FerriKerstin HartmannMark LaibleUgur SahinZsuzsanna VargaChiara LupiFabrizio StracciAngelo SidoniPublished in: PloS one (2021)
Determination of the breast cancer biomarkers ER, PR, HER2 and Ki67 at the mRNA level shows high degree of correlation with IHC and compares well with correlations between original with subsequent independent manual or semi-automated IHC assessments. The use of methods with wider dynamic range and higher reproducibility such as RT-qPCR may offer more precise assessment of endocrine responsiveness, improve Ki67 standardization and help resolve HER2 cases that remain equivocal or ambiguous by IHC/FISH. In summary, our findings seem to configure RT-qPCR as a complementary method to be used in cases of either equivocal results or presenting, at the traditional determination assays, biomarkers expressions close to the cut-off values.